That we will.
Your theory is as reasonably as any other. In fact my very first suspicion, was that the BOD wants a quick resolution and the opportunity to bank some money while MT wanted to take it further. Was there any mention of Pre Clinical work on other conditions in the Quarterly ? I cant be bothered checking at the moment.
No matter what shenanigans may be going on, ODD will make Pharmaust a very attractive proposition.
Just guessing everyone, so don't take these comments to seriously. But it would explain a host of curiosities.
- Forums
- ASX - By Stock
- PAA
- The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-1274
-
- There are more pages in this discussion • 151 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
(20min delay)
|
|||||
Last
22.0¢ |
Change
0.015(7.32%) |
Mkt cap ! $95.68M |
Open | High | Low | Value | Volume |
21.5¢ | 22.0¢ | 21.5¢ | $410.2K | 1.903M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 38500 | 22.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.5¢ | 2084 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 8500 | 0.220 |
5 | 83414 | 0.215 |
5 | 294678 | 0.210 |
4 | 243125 | 0.205 |
15 | 555470 | 0.200 |
Price($) | Vol. | No. |
---|---|---|
0.225 | 2084 | 1 |
0.230 | 81404 | 4 |
0.235 | 74418 | 1 |
0.240 | 134752 | 2 |
0.245 | 196127 | 3 |
Last trade - 15.22pm 15/07/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online